Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Consulting agrmnt
NightHawk Biosciences, Inc. (HTBX) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/14/2022 8-K Quarterly results
04/20/2022 8-K Investor presentation
Docs: "PATENT LICENSE AGREEMENT"
01/05/2022 8-K Investor presentation
11/30/2021 8-K Investor presentation
Docs: "CORE VACCINE TECHNOLOGY CORE VACCINE SUPPORTING CLINICAL DATA"
08/27/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
02/09/2021 8-K Quarterly results
11/29/2019 8-K Investor presentation
Docs: "Presentation materials to be provided at Heat Biologics, Inc. presentations"
06/24/2019 8-K Quarterly results
05/07/2019 8-K Investor presentation
Docs: "Heat Biologics, Inc. Corporate Presentation"
04/02/2019 8-K Investor presentation
Docs: "Heat Biologics, Inc. poster presentation",
"Heat Biologics Delivers Poster Presentation at the AACR Annual Meeting 2019",
"Heat Biologics, Inc. poster presentation"
02/28/2019 8-K Investor presentation
Docs: "Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior checkpoint inhibitor therapy",
"Heat Biologics, Inc. Investor Presentation"
02/28/2019 8-K Quarterly results
01/08/2019 8-K Investor presentation
Docs: "Heat Biologics, Inc. investor presentation dated January 2019"
04/20/2018 8-K Investor presentation
Docs: "Heat Biologics, Inc. investor presentation"
03/06/2018 8-K Investor presentation
Docs: "POWER POINT PRESENTATION"
02/28/2018 8-K Investor presentation
Docs: "POWER POINT PRESENTATION",
"POWER POINT PRESENTATION"
05/31/2017 8-K Form 8-K - Current report
01/06/2017 8-K Form 8-K - Current report
06/06/2016 8-K Form 8-K - Current report
03/15/2016 8-K Investor presentation
Docs: "Presentation materials to be provided at Heat Biologics, Inc.'s presentations"
01/27/2016 8-K Investor presentation
Docs: "Heat Biologics, Inc. presentation materials"
11/06/2015 8-K Investor presentation
Docs: "Presentation materials to be provided at Heat Biologics, Inc.'s presentations"
09/01/2015 8-K Investor presentation
Docs: "Heat Biologics Announces Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC",
"INVESTOR PRESENTATION"
06/15/2015 8-K Investor presentation
Docs: "Heat Biologics Announces Development of ComPACT, a Next Generation Combination Immunotherapy Platform",
"POWER POINT PRESENTATION",
"POSTER"
05/29/2015 8-K Investor presentation
Docs: "6 12 18 24 30 36 0.25 0.50 1.00 0.75"
11/19/2014 8-K Investor presentation
Docs: "6 12 18 24 30 36 0.25 0.50 1.00 0.75"
09/08/2014 8-K Investor presentation
Docs: "Presentation materials to be provided at Heat Biologics, Inc.'s presentations"
05/28/2014 8-K Investor presentation
Docs: "PRESENTATION"
03/20/2014 8-K Investor presentation
Docs: "PRESENTATION"
01/13/2014 8-K Investor presentation
Docs: "January 2014 Forward Looking Statements This presentation includes statements that are, or may be deemed, ‘‘forward-looking statements.’’ In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately” or, in each case, their negative or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. They appear in a number of places throughout this presentation and include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, our ongoing and planned discov..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy